These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 3771432

  • 1. Activity of penicillin combined with an aminoglycoside against group B streptococci in vitro and in experimental endocarditis.
    Backes RJ, Rouse MS, Henry NK, Geraci JE, Wilson WR.
    J Antimicrob Chemother; 1986 Oct; 18(4):491-8. PubMed ID: 3771432
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis.
    Enzler MJ, Rouse MS, Henry NK, Geraci JE, Wilson WR.
    J Infect Dis; 1987 May; 155(5):954-8. PubMed ID: 3644854
    [Abstract] [Full Text] [Related]

  • 3. Group B streptococcal infective endocarditis.
    Backes RJ, Wilson WR, Geraci JE.
    Arch Intern Med; 1985 Apr; 145(4):693-6. PubMed ID: 3885892
    [Abstract] [Full Text] [Related]

  • 4. Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals.
    Wilson WR, Zak O, Sande MA.
    J Infect Dis; 1985 Jun; 151(6):1028-33. PubMed ID: 3846608
    [Abstract] [Full Text] [Related]

  • 5. Treatment of endocarditis caused by relatively resistant nonenterococcal streptococci: is penicillin enough?
    DiNubile MJ.
    Rev Infect Dis; 1990 Jun; 12(1):112-7. PubMed ID: 2405464
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.
    Durack DT, Pelletier LL, Petersdorf RG.
    J Clin Invest; 1974 Mar; 53(3):829-33. PubMed ID: 4492776
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis.
    Brennan RO, Durack DT.
    Antimicrob Agents Chemother; 1983 Feb; 23(2):273-7. PubMed ID: 6838188
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis.
    Fernandez-Guerrero M, Rouse MS, Henry NK, Geraci JE, Wilson WR.
    Antimicrob Agents Chemother; 1987 Mar; 31(3):430-3. PubMed ID: 3579260
    [Abstract] [Full Text] [Related]

  • 12. Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin.
    Henry NK, Wilson WR, Geraci JE.
    Antimicrob Agents Chemother; 1986 Nov; 30(5):725-8. PubMed ID: 3800348
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci.
    Henry NK, Wilson WR, Roberts RB, Acar JF, Geraci JE.
    Antimicrob Agents Chemother; 1986 Sep; 30(3):465-7. PubMed ID: 3777910
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.